Lachlan Brown

Stock Analyst at William Blair

(2.23)
# 2,204
Out of 4,667 analysts
4
Total ratings
66.67%
Success rate
5.92%
Average return

Stocks Rated by Lachlan Brown

Apellis Pharmaceuticals
Oct 16, 2024
Initiates: Outperform
Price Target: n/a
Current: $27.75
Upside: -
The Descartes Systems Group
May 14, 2024
Initiates: Neutral
Price Target: $90
Current: $114.33
Upside: -21.28%
Manhattan Associates
May 14, 2024
Initiates: Buy
Price Target: $260
Current: $271.89
Upside: -4.37%
SPS Commerce
May 14, 2024
Initiates: Buy
Price Target: $220
Current: $186.32
Upside: +18.08%